Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Sigyn Therapy™
  • Oncology
    • Overview
    • ImmunePrep™
    • ChemoPrep™
    • ChemoPure™
  • News
    • Press Releases
    • Presentations
    • Resources
  • Media
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Email Alerts
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • CEO Notes

Press Releases

News

News

  • Press Releases
  • Presentations
  • Resources
Jan 26, 2021 8:30am EST

Sigyn Therapeutics Appoints Eric Lynam as Head of Clinical Affairs

Jan 12, 2021 8:30am EST

Sigyn Therapeutics (SIGY) CEO Note: Overcoming the Limitations of Previous Cytokine Storm Treatment Strategies

Jan 06, 2021 8:30am EST

Sigyn Therapeutics™ Reports Results of Pilot Study to Address Inflammatory CytoVesicles

Dec 01, 2020 8:45am EST

Sigyn Therapeutics™ Reports Simultaneous Clearance of Endotoxin and Inflammatory Cytokines From Human Blood Plasma

Nov 02, 2020 7:30am EST

Sigyn Therapeutics (SIGY) CEO Note: Rethinking the Treatment of Sepsis and Other Life-Threatening Inflammatory Conditions

Oct 19, 2020 4:30pm EDT

Sigyn Therapeutics Announces Completion of Merger with Reign Resources

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
RSS
© 2025 Sigyn Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap